Senior Investigator, TIMI Study Group, Staff Physician, Cardiovascular Division, Brigham and Women’s Hospital. Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Dr Robert P. Giugliano is a Senior Investigator with the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Staff Physician in the Cardiovascular Division at the Brigham and Women’s Hospital and Associate Professor of Medicine at Harvard Medical School. He graduated summa cum laude and phi beta kappa, and received his medical degree at Harvard Medical School. Dr Giugliano completed his internship, residency, and chief residency at Cedars-Sinai Medical Center, Los Angeles and then returned to Boston as a Cardiology Fellow at the Massachusetts General Hospital.

Dr Giugliano joined the Brigham and Women’s Hospital in 1996, worked with the TIMI Study Group, and completed a Master of Science degree in epidemiology at the Harvard School of Public Health and joined the Cardiovascular Division in 1997.

His research interests include novel antithrombotic therapies for atrial fibrillation and acute coronary syndromes (ACS), lipid-lowering therapies and the assessment of outcomes in patients with ACS. Dr Giugliano has authored more than 250 original articles and 150 reviews/editorials/book chapters. He is the Founding Scientific Advisor and Editor-in-Chief for MD Conference Express, Co-Editor-in-Chief of Cardiology and Therapy, and serves on editorial boards for Circulation, The American Heart Journal, Clinical Cardiology, Cor et Vasa, Hospital Practice, Cardiovascular Therapeutics and Clinical Pathways in Cardiology.

Dr Giugliano is the Principal TIMI Investigator for the ENGAGE AF-TIMI 48, LAPLACE-TIMI 57 and EARLY ACS trials, ANTHEM-TIMI 32 and Executive Committee member of the IMPROVE-IT. FOURIER, and EBBINGHAUS trials.